Table 2 Outcomes and resource utilization

Length of stay (days), Mean (SD); (min – max)

26.9 (25.0); (1.0 – 269.0)

 Survivors length of stay, Mean (SD); (min – max)

29.2 (28.2); (4.0 – 269.0)

 Non-survivors length of stay, Mean (SD); (min – max)

24.2 (20.4); (1.0 – 121.0)

Hospital ICU stay (days), Mean (SD); (min – max)

15.8 (15.3); (1 – 114.0)

Re-hospitalization ¹, n (%)

5 (1.21%)

Mortality within hospital, n (%)

188 (45.63%)

 Expired within 30 days of hospitalization, n (%)

117 (33.05%)

No. of patients with at least one day on mechanical ventilation, n (%)

298 (72.33%)

 Length of mechanical ventilation (days), Mean (SD); (min – max)

16.5 (15.8); (1.0 – 111.0)

No. of patients with bronchoscopy (%)

60 (14.56%)

No. of patients with needle biopsy (%)

221 (53.64%)

Antifungal Therapies

Index Event (IE) Day ² , Mean (SD); (min – max)

8.6 (9.2); (1.0 – 85.0)

No. of Antifungal therapies per patient, Mean (SD); (min – max)

1.70 (0.81); (1.00 – 4.00)

Length of Antifungal therapy (days), Mean (SD); (min – max)

14.6 (13.0); (1.0 – 122.0)

 Length of therapy (Survivors)

16.3 (12.8); (5.0 – 122.0)

 Length of therapy (Non-survivors)

12.6 (13.1); (1.0 – 93.0)